iRadimed IRMD Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Amortization of extended maintenance agreements | $659K+17.7% | —— | —— | —— | $560K— | |
| Disposables | $4.89M-1.3% | —— | —— | —— | $4.95M— | |
| Ferro Magnetic Detection Systems | $621K+48.6% | —— | —— | —— | $418K— | |
| MRI Compatible IV Infusion Pumps | $7.66M+27.8% | —— | —— | —— | $6M— | |
| MRI Compatible Patient Vital Signs Monitoring Systems | $7.11M+8.6% | —— | —— | —— | $6.55M— | |
| Services and other | $1.04M+0.1% | —— | —— | —— | $1.04M— | |
| Total Revenue by Geography | ||||||
| International | $3.95M+11.1% | $4.39M+52.3% | $3.09M-1.0% | $2.22M— | $3.56M— | |
| United States | $18.03M+13.0% | $18.3M+10.9% | $18.11M+19.1% | $18.19M+17.5% | $15.95M+19.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does iRadimed break its business down?
- iRadimed (IRMD) reports total revenue by product across 6 parts — Amortization of extended maintenance agreements, Disposables, Ferro Magnetic Detection Systems, MRI Compatible IV Infusion Pumps and MRI Compatible Patient Vital Signs Monitoring Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does iRadimed's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in iRadimed's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
